Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Autoimmune polyendocrine syndrome type 3
Другие языки:

Autoimmune polyendocrine syndrome type 3

Подписчиков: 0, рейтинг: 0
Autoimmune Polyendocrine Syndrome, Type III
Other names Autoimmune Polyendocrinopathy Type III; APS III or PAS III
Specialty Endocrinology, Rheumatology
Symptoms Any symptoms associated with its constituent diseases
Complications Autoimmune thyroiditis (Always), Celiac Disease, Type I Diabetes, Autoimmune hypophysitis, Systemic Lupus Erythematosus, Sjögren's Syndrome, Vitiligo (May or May not be Present)
Usual onset Any Age
Duration Lifelong
Types APS 3A: Autoimmune thyroiditis with Immune Mediated diabetes mellitus;

APS 3B: Autoimmune thyroiditis with Pernicious anemia;

APS 3C: Autoimmune thyroiditis with Vitiligo and/or Alopecia and/or Another Organ Specific Disease
Causes Combination of Genetic and Environmental Factors
Risk factors Family History of APS III or other Autoimmune Diseases
Diagnostic method Serum Antibody Assays; Autoimmune Thyroiditis Required for Diagnosis
Differential diagnosis Autoimmune Polyendocrine Syndrome Type II, APECED, IPEX
Prevention N/A
Treatment Depends on Constituent Diseases
Prognosis Normal Lifespan
Frequency ~ 2-3% of population

Autoimmune Polyendocrine Syndrome, Type III (APS III) is a multi-system autoimmune disease characterized by lymphocytic infiltration of multiple endocrine and non-endocrine glands. In APS III, autoimmune thyroiditis must be present, but the adrenal cortex is not involved.

APS III is a member of a group of diseases, each known as an Autoimmune polyendocrine syndrome. It is strongly related Autoimmune polyendocrine syndrome type 2; however, Type II requires a diagnosis of Addison's Disease in addition to autoimmune thyroiditis.

History

Autoimmune Polyendocrine Syndrome Type III was first rigorously defined in 1980 by physicians Neufeld and Blizzard in their classification of Autoimmune Polyendocrine Syndromes. The distinction between Types II and III is purely clinical, and any etiological difference was not yet outlined or discovered. The concept of Polyendocrine Failure originates from the work of German pathologist Martin Benno Schmidt, who first described a patient with simultaneous adrenal insufficiency and hypothyroidism in 1926.

In Popular Culture

External links



Новое сообщение